Celldex Therapeutics
CLDX
$42.56
Share price
4.16%
Change (1 day)
27.88%
Change (1 year)
Categories
Celldex Therapeutics (CLDX) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $36.45 M
According to Celldex Therapeutics's latest financial reports the company's total liabilities are $36.45 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Celldex Therapeutics - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $36.45 M | 37.41% |
| 2022-12-31 | $26.53 M | 5.37% |
| 2021-12-31 | $25.17 M | -4.92% |
| 2020-12-31 | $26.48 M | -8.39% |
| 2019-12-31 | $28.9 M | -8.95% |
| 2018-12-31 | $31.74 M | -59.94% |
| 2017-12-31 | $79.25 M | -32.79% |
| 2016-12-31 | $0.11 B | 148.38% |
| 2015-12-31 | $47.47 M | 30.6% |
| 2014-12-31 | $36.35 M | 33.16% |
| 2013-12-31 | $27.3 M | -8.29% |
| 2012-12-31 | $29.76 M | 1.69% |
| 2011-12-31 | $29.27 M | -15.61% |
| 2010-12-31 | $34.68 M | -47.91% |
| 2009-12-31 | $66.59 M | 28.92% |
| 2008-12-31 | $51.65 M | 391.69% |
| 2007-12-31 | $10.5 M | -82.29% |
| 2006-12-31 | $59.31 M | 281.16% |
| 2005-12-31 | $15.56 M | 110.42% |
| 2004-12-31 | $7.39 M | 118.46% |
| 2003-12-31 | $3.38 M | -12.94% |
| 2002-12-31 | $3.88 M | -52.67% |
| 2001-12-31 | $8.21 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $137.21 B | 376,279.75% | 🇺🇸 USA |
 Amgen AMGN | $90.92 B | 249,302.02% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $57.22 B | 156,867.58% | 🇬🇧 UK |
 Titan Pharmaceuticals
TTNP | $1.44 M | -96.04% | 🇺🇸 USA |
 Seagen
SGEN | $1.08 B | 2,873.01% | 🇺🇸 USA |
 Agenus
AGEN | $0.46 B | 1,168.09% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | $1.17 B | 3,120.05% | 🇺🇸 USA |